台灣生技新藥產業研發投入與股價關聯性之探討

Chung-Hsien Chang; 張仲賢

請用此 Handle URI 來引用此文件： http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/5286

完整後設資料紀錄

DC 欄位	值	語言
dc.contributor.advisor	李顯峰(Hsien-Feng Lee)
dc.contributor.author	Chung-Hsien Chang	en
dc.contributor.author	張仲賢	zh_TW
dc.date.accessioned	2021-05-15T17:55:05Z	-
dc.date.available	2015-07-29
dc.date.available	2021-05-15T17:55:05Z	-
dc.date.copyright	2014-07-29
dc.date.issued	2014
dc.date.submitted	2014-07-17
dc.identifier.citation	參考文獻中文文獻生技產業白皮書2013。經濟部工業局。生物技術產業年鑑2012。經濟部技術處、財團法人生物技術開發中心。醫藥產業年鑑2013。經濟部技術處、財團法人生物技術開發中心。王為敏、林晉源、徐慶昇、文端廉。2002。生技投資的億萬商機。台北：時報文化出版社。王宇峰。2010。我國上市公司R&D信息披露及其價值相關性研究。博士論文。中國湖南省長沙市：中南大學。林惠玲、陳正倉。2002。研究發展、專利權與經濟效益：台灣1996-2000年追蹤資料之驗證。行政院國家科學委員會專題研究計畫成果報告。林今煥。2012。研究發展支出與企業經營績效之攸關性－以我國半導體上市上櫃公司為例。碩士論文。台北：國立政治大學金融研究所。林劭遠。2013。航運企業之價值及其動因比較研究-以新興 V.S 裕民公司為例。碩士論文。嘉義：國立中正大學企業管理研究所。金成隆、林修葳、紀信義。2004。專利權的價值攸關性：從企業生命週期論析。管理學報；21卷 2 期：175 – 197。洪肇嘉。2012。專利權與經營績效、企業價值關係之研究。碩士論文。台南：成功大學會計研究所。張娉。2011。高新技術企業研發支出價值相關性研究。碩士論文。中國安徽省會合肥市：安徽大學。張馨文。2014。重大資本支出後的經營績效-以製藥產業為例。台南：成功大學財務金融研究所碩士在職專班。黃台心。2009。計量經濟學。二版:457-484。台北:新陸。歐進士。1998。我國企業研究發展與經營績效關聯之實證研究。中山管理評論，6(2)：357-386。賴鈺城、李崑進、莊世金、陳盈仁。2010。投資人對於研發與資本支出之回應。　　人文暨社會科學期刊；第六卷；第二期：85-98。謝佩芬。2004。財務指標與非會計資訊對股價之影響－Ohlson模型之延伸應用。碩士論文。桃園：私立中原大學國際貿易研究所。謝朝慶。2011。商業模式創新與企業價值分析-以85度C為例。桃園：國立中央大學財務金融學研究所碩士在職專班。外文文獻 Baltagi, B.H., 2005. Econometric Analysis of Panel Data.3rd ed.:4-9.U.K.:John Wiley & Sons Ltd. Bosworth, D. and Rogers, M., 2002. Market Value, R&D and Intellectual Property: An Empirical Analysis of Large Australian Firms. Economic Record.Volume 77, Issue 239:323–337. Chauvin, KW and Hirschey, M., 1993. Advertising, R&D expenditures and the market value of the firm. Financial management. Vol. 22, No. 4, Winter: 128-140. Connolly, R.A., 1988. Market Value and patents: A Bayesian approach. Economics Letters. Volume 27, Issue 1:83–87. Edvinsson, L. and Malone, M.S., 1997. Intellectual Capital: Realizing Your　Company’s True Value By Finding Its Hidden Brainpower, 1th Edition, HarperCollins Publishers, Inc: New York. Ely, K., Simko, P. J. and Thomas, L.G., 2003. The Usefulness of Biotechnology Firms' Drug Development Status in the Evaluation of Research and Development Costs. Journal of Accounting, Auditing & Finance January vol. 18 no. 1:163-196. Greene, W. H., 2003. NOLOGIT- Reference Guide, Version3.0, Econometric Software Inc. Hall, B.H., Jaffe, A. and Trajtenberg, Ma., 2005. Market Value and Patent Citations. The RAND Journal of Economics .Vol. 36, No. 1, Spring :16-38. Han, B.H. and Manry, D., 2004. The Value-relevance of R&D and Advertising Expenditures: Evidence from Korea. The International Journal of Accounting. Volume 39, Issue 2:155–173. Hausman, .J.A., 1978. Specification tests in econometrics.Econometrica .Vol. 46, No. 6, 1251-1271. Henderson, B. C., Kobelsky, K., Richardson, V. J. and Smith, R. E., 2010. The Relevance of Information Technology Expenditures. Journal of Information Systems: Fall, Vol. 24, No. 2: 39-77. Hirschey, M. and Weygandt, J.J., 1985. Amortization Policy for Advertising and Research and Development Expenditures. Journal of Accounting Research .Vol. 23, No. 1, Spring: 326-335. Hirschey, M., Richardson, V.J. and Scholz, S., 2001. Value Relevance of Nonfinancial Information: The Case of Patent Data. Review of Quantitative Finance and Accounting. Volume 17, Issue 3: 223-235. Lewellen, W.G. and Badrinath, S.G., 1997. On the Measurement of Tobin’s Q. Journal of Financial Economics,44(1),77-122. Lee, S-C; Lin, C-T; Chang, P-T, 2011. An Ohlson valuation framework for valuing corporate governance: The case of Taiwan. Pacific-Basin Finance Journal.- Elsevier, ISSN 0927-538X. - Vol. 19 : p. 420-434. Nilsson, H. and Liljeblom, E., 2003. Essays on the value relevance of financial statment information. Studier iforetagsekonomi. Serie B, no.50, ISSN 0346-8291. Ohlson, J.A., 1995. Earnings book values, and dividends in equity valuation. Contemporary Accounting Research, 11, 661-687. Oswald, D.R, 2007. The Determinants and Value Relevance of the Choice of Accounting for Research and Development Expenditures in the United Kingdom. Journal of Business Finance & Accounting. Volume 35, Issue 1-2:1–24. Sougiannis, T., 1994. The Accounting Based Valuation of Corporate R&D. The Accounting Review. Vol. 69, No. 1, Jan., 1994.44-68. Su, Y.L. and Liu, C.T., 2012. A Study of the Relationship of Corporate Governance and Stock Price of the Marine Industry in Taiwan: Using the Ohlson Model. Third International Conference on Innovations in Bio-Inspired Computing and Applications:177 - 180 Swartz, G.E., Swartz N-P. and Firer S., 2006. An empirical examination of the value relevance of intellectual capital using the Ohlson (1995) valuation model. Meditari Accountancy Research, Vol. 14 Iss: 2: 67 – 81. Xu, B., Magnan, M.L. and P.E. Andre., , 2007. The Stock Market Valuation of R&D Information in Biotech Firms. Contemporary Accounting Research. Volume 24, Issue 4, Winter :1291–1318.
dc.identifier.uri	http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/5286	-
dc.description.abstract	生技新藥產業為近年來備受矚目的產業之一，而我國為促進生技新藥產業之發展，於2007年頒布了《生技新藥產業法展條例》，提供生技新藥公司們各種租稅優惠措施，鼓勵研發與投資，對於生技新藥產業而言，研發投入是不可或缺的一項重要因素。　　本研究旨在探討探討生技新藥公司之研發投入及專利權之獲取對於其公司股價之影響性，利用Ohlson(1995)股權評價模型為基礎，選取我國於2008年至2013年之24間生技新藥公司作為樣本，採用縱橫資料(Panel Data)進行分析。　　實證結果顯示： 1. 生技新藥公司之研發費用對於公司股價具有正向顯著之影響。 2. 生技新藥公司之專利權數並未對公司股價具有顯著性關係。 3. 生技新藥公司之研發費用並未對公司股價具有遞延效果。 4. 生技新藥公司之規模與公司股價呈現反向顯著關係。 5. 生技新藥公司之營收成長率與公司股價呈現正向顯著關係。	zh_TW
dc.description.abstract	In the 21th century, the bio-pharmaceutical industry is one of the rising star industries in the limelight. To promote the development of the bio-pharmaceutical industry, Taiwan government has promulgated the ‘Act For The Development Of Biotech And New Pharmaceuticals Industry’ which provides lots of tax incentives for the bio-pharmaceutical firms to encourage R&D and investment activities. For bio-pharmaceutical industry, R&D is one of the essential factors indispensably. This research is focus on exploring the relationships between R&D investments, obtained-patents and the stock price of the bio-pharmaceutical firms. Based on the Ohlson(1995) Model, choosing 24 bio-pharmaceutical firms from 2008 to 2013 in Taiwan as sample for empirical analysis by Panel data. Our empirical findings are following: 1. The R&D expenditure is significant positively affect the stock price of bio-pharmaceutical firms. 2. Obtained-patents has no significant influence on the stock price of bio-pharmaceutical firms. 3. The R&D expenditure has no deferred effects to the stock price of bio-pharmaceutical firms. 4. The firm size is significant negatively affect the stock price of bio-pharmaceutical firms. 5. The sales growth rate is significant negatively affect the stock price of bio-pharmaceutical firms.	en
dc.description.provenance	Made available in DSpace on 2021-05-15T17:55:05Z (GMT). No. of bitstreams: 1 ntu-103-R01323018-1.pdf: 758036 bytes, checksum: 9aff81c5f28dd0d21c586514dc3b42bb (MD5) Previous issue date: 2014	en
dc.description.tableofcontents	目錄第一章緒論 1 第一節研究背景與動機 1 第二節研究目的與對象 5 第三節研究架構 6 第二章生技產業概述 7 第一節生技產業簡介 7 第二節全球生技藥品產業概況 12 第三節台灣生技新藥產業概況 15 第三章文獻探討 25 第一節研究發展投入、專利權與股價 25 第二節股權評價模型－Ohlson Model 30 第四章研究方法 34 第一節研究方法介紹 34 第二節實證流程 40 第三節模型之建立 41 第四節變數定義與衡量 44 第五節樣本與資料來源 48 第五章實證研究結果與分析 50 第一節敘述性統計分析 50 第二節相關性統計分析 54 第三節實證結果分析 56 第六章結論與建議 63 第一節結論 63 第二節限制與建議 64 參考文獻 66 附錄　《生技新藥產業發展條例》 71
dc.language.iso	zh-TW
dc.subject	縱橫資料	zh_TW
dc.subject	生技新藥產業	zh_TW
dc.subject	研發	zh_TW
dc.subject	專利權	zh_TW
dc.subject	Ohlson(1995)股權評價模型	zh_TW
dc.subject	R&D	en
dc.subject	Panel data	en
dc.subject	Ohlson(1995) Model	en
dc.subject	Patents	en
dc.subject	bio-pharmaceutical firms	en
dc.title	台灣生技新藥產業研發投入與股價關聯性之探討	zh_TW
dc.title	An Empirical Study of the Relationships between R&D and Stock Price of Taiwanese Bio-pharmaceutical Industry	en
dc.type	Thesis
dc.date.schoolyear	102-2
dc.description.degree	碩士
dc.contributor.coadvisor	孫智麗(Chih-Li Sun)
dc.contributor.oralexamcommittee	羅光達(Kuang-Ta Lo)
dc.subject.keyword	生技新藥產業,研發,專利權,Ohlson(1995)股權評價模型,縱橫資料,	zh_TW
dc.subject.keyword	bio-pharmaceutical firms,R&D,Patents,Ohlson(1995) Model,Panel data,	en
dc.relation.page	73
dc.rights.note	同意授權(全球公開)
dc.date.accepted	2014-07-17
dc.contributor.author-college	社會科學院	zh_TW
dc.contributor.author-dept	經濟學研究所	zh_TW
顯示於系所單位：	經濟學系

文件中的檔案：

檔案	大小	格式
ntu-103-1.pdf	740.27 kB	Adobe PDF	檢視/開啟

顯示文件簡單紀錄

系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。